With up to 90% of pipeline drugs facing significant solubility challenges, data and predictive tools for preclinical solubility and bioavailability enhancement are becoming increasingly strategic.
QUAKERTOWN, Pa.--(BUSINESS WIRE)--Microsize today announced the strategic investment and partnership with Helsinki-based The Solubility Company. Microsize's investment accelerates plans for The ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果